Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 5Phase 1 3Phase 1/2 2

Status

Active not recruiting 5Terminated 2Completed 2

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 4Neoplasm Metastasis 1Advanced HER2+Breast Cancer 1

Interventions

Carboplatin 106Cisplatin 97Paclitaxel 78pembrolizumab 69Gemcitabine 59Pemetrexed 49Cyclophosphamide 46Docetaxel 45Dexamethasone 45durvalumab 44Capecitabine 44Radiotherapy 40Nivolumab 37Lenalidomide 37Specimen Handling 36Doxorubicin 36Rituximab 34Oxaliplatin 34Bevacizumab 33Magnetic Resonance Spectroscopy 32Fluorouracil 32atezolizumab 29Etoposide 29Vincristine 26Radiation 26Leucovorin 26Letrozole 24Bortezomib 24Fulvestrant 23Prednisone 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Alpelisib × Clear all
NCT05038735 2026-06-02

EPIK-B5

Novartis

Phase 3 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

NCT05646862 2026-05-06

INAVO121

Hoffmann-La Roche

Phase 3 Active not recruiting
420 enrolled
Breast

Breast Neoplasms

NCT04208178 2026-04-02

EPIK-B2

Novartis

Phase 3 Active not recruiting
19 enrolled
Breast

Advanced HER2+Breast Cancer

NCT05501886 2026-02-10

VIKTORIA-1

Celcuity Inc

Phase 3 Active not recruiting
701 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT05063786 2025-09-08

ALPHABET

Spanish Breast Cancer Research Group

Phase 3 Active not recruiting
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡